US Stock MarketDetailed Quotes

RGEN Repligen

Watchlist
  • 127.240
  • -6.170-4.62%
Close Mar 31 16:00 ET
  • 127.130
  • -0.110-0.09%
Pre 08:54 ET
7.14BMarket Cap-276.61P/E (TTM)

About Repligen Company

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Company Profile

SymbolRGEN
Company NameRepligen
Listing DateMay 6, 1986
Founded1981
CEOMr. Olivier Loeillot
MarketNASDAQ
Employees1778
Fiscal Year Ends12-31
Address41 Seyon Street,Building 1, Suite 100
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-250-0111
Websitehttp://www.repligen.com

Company Executives

  • Name
  • Position
  • Salary
  • Olivier Loeillot
  • Director, President and Chief Executive Officer
  • 5.45M
  • James R. Bylund
  • Chief Operating Officer
  • 3.74M
  • Jason K. Garland
  • Chief Financial Officer and Principal Accounting Officer
  • 2.03M
  • Christine Gebski
  • Senior Vice President, Filtration and Chromatography
  • 1.66M
  • Ralf Kuriyel, PhD
  • Senior Vice President, Research and Development
  • 1.66M
  • Tony J. Hunt
  • Executive Chairman of the Board
  • 7.93M
  • Margaret A. Pax
  • Independent Director
  • --
  • Karen A. Dawes, M.A.
  • Lead Independent Director
  • 431.12K
  • Carrie Eglinton Manner
  • Independent Director
  • 287.84K
  • Nicolas M. Barthelemy
  • Independent Director
  • 307.84K
  • Glenn P. Muir
  • Independent Director
  • 322.84K
  • Dr. Rohin Mhatre, PhD
  • Independent Director
  • 287.84K
  • Dr. Martin D. Madaus,PhD
  • Independent Director
  • 453.50K
  • Dr. Konstantin Konstantinov, PhD
  • Independent Director
  • 282.84K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Trump's comeback to the Office

Following Trump's Policies to Seek Investment Opportunities

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025